ROCHE DIAGNOSTICS LIMITED

Location

Founded

1956-09-14

Risk Signals

24759 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Business Services, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about ROCHE DIAGNOSTICS LIMITED

Live alerts from global media, monitored by Business Radar

Natco Pharma shares legal update on Risdiplam patent; stock up 3% - Natco Pharma shares legal update on Risdiplam patent; stock up 3% BusinessToday

2025-04-08 (businesstoday.in)

Natco Pharma shares legal update on Risdiplam patent; stock up 3% - Natco Pharma shares legal update on Risdiplam patent; stock up 3% BusinessToday

Natco Pharma share price: The stock rose 2.95 per cent to hit a high of Rs 789. It was last seen trading 1.44 per cent up at Rs 777.45. At this price, it has crashed 44.42 per cent on a year-to-date (YTD) basis.

Read more
Facilities do not always begin with bricks, Genentech - BioProcess insider

2023-03-01 (bioprocessintl.com)

Facilities do not always begin with bricks, Genentech - BioProcess insider

The buildout of a facility ends with technology choices but starts with a purpose, vision, and people, says Roche’s Genentech.

Read more
J&J and Roche feeling the biosimilar bite in Q3 - BioProcess Insider

2022-10-19 (bioprocessintl.com)

J&J and Roche feeling the biosimilar bite in Q3 - BioProcess Insider

Both J&J and Roche are feeling pressure from biosimilars as sales of blockbuster products such as Remicade and Lucentis drop in Q3.

Read more
Swiss pharma executive gets US sanction for insider trading

2019-08-16 (swissinfo.ch)

Swiss pharma executive gets US sanction for insider trading

The US Securities and Exchange Commission has fined Lorenz Erne, a former senior executive at Swiss pharmaceutical firm Roche, for insider trading.

Read more
Swiss pharma executive gets US sanction for insider trading

2019-08-16 (swissinfo.ch)

Swiss pharma executive gets US sanction for insider trading

The US Securities and Exchange Commission has fined Lorenz Erne, a former senior executive at Swiss pharmaceutical firm Roche, for insider trading.

Read more

Never miss a headline about ROCHE DIAGNOSTICS LIMITED

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages